SynthesisESMO open2024

Trastuzumab deruxtecan in human epidermal growth factor receptor 2-positive breast cancer brain metastases: a systematic review and meta-analysis.

I Michelon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.